0001209191-17-029369.txt : 20170502
0001209191-17-029369.hdr.sgml : 20170502
20170502182716
ACCESSION NUMBER: 0001209191-17-029369
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170502
DATE AS OF CHANGE: 20170502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xencor Inc
CENTRAL INDEX KEY: 0001326732
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201622502
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 WEST LEMON AVE
CITY: MONROVIA
STATE: CA
ZIP: 91016
BUSINESS PHONE: 626-305-5900
MAIL ADDRESS:
STREET 1: 111 WEST LEMON AVE
CITY: MONROVIA
STATE: CA
ZIP: 91016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baracchini Edgardo Jr
CENTRAL INDEX KEY: 0001291972
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36182
FILM NUMBER: 17806601
MAIL ADDRESS:
STREET 1: C/O METABASIS THERAPEUTICS
STREET 2: 9390 TOWNE CENTRE DRIVE, BLDG. 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-01
0
0001326732
Xencor Inc
XNCR
0001291972
Baracchini Edgardo Jr
C/O XENCOR, INC.
111 WEST LEMON AVENUE
MONROVIA
CA
91016
0
1
0
0
Chief Business Officer
Common Stock
2017-05-01
4
M
0
9818
0.59
A
9818
D
Common Stock
2017-05-01
4
S
0
9818
26.01
D
0
D
Common Stock
2017-05-02
4
M
0
750
0.59
A
750
D
Common Stock
2017-05-02
4
S
0
750
26.068
D
0
D
Stock Option (right to buy)
0.59
2017-05-01
4
M
0
9818
0.00
D
2020-01-17
Common Stock
9818
130628
D
Stock Option (right to buy)
0.59
2017-05-02
4
M
0
750
0.00
D
2020-01-17
Common Stock
750
129878
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.0217, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
25% of the shares subject to the option vested on the one year anniversary of January 12, 2010 (the "Vesting Commencement Date"), and 1/48th of the shares vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
/s/ John J. Kuch, Attorney-in-Fact
2017-05-02